1984Clinical Infectious DiseasesRequires access

Cryptosporidiosis: Clinical, Epidemiologic, and Parasitologic Review

Thomas R. Navin, Dennis D. Juranek

Open publisher page 314 citations

Abstract

Cryptosporidium, an intestinal protozoan parasite, is a well-known cause of diarrhea in animals but has been recognized only recently as a cause of human disease. Since 1976, 58 cases of cryptosporidiosis in humans have been reported; 18 of the patients had normal immune function, and 40 had various immunologic abnormalities, the most common of which, acquired immune deficiency syndrome (AIDS), occurred in 33 patients. Patients with normal immune function had self-limited diarrhea, but patients with immunologic abnormalities often developed severe, irreversible diarrhea; 22 patients have died. The diagnosis of cryptosporidiosis can now be made noninvasively, but increased diagnostic proficiency has led to little improvement in control or treatment of the disease. Although 23 compounds have been evaluated in experimentally infected animals and 20 drugs have been used in human clinical trials, no effective chemotherapeutic agent for cryptosporidiosis has been identified to date.

About this research paper

What this paper is about

Cryptosporidium, an intestinal protozoan parasite, is a well-known cause of diarrhea in animals but has been recognized only recently as a cause of human disease. Since 1976, 58 cases of cryptosporidiosis in humans have been reported; 18 of the patients had normal immune function, and 40 had various immunologic abnormalities, the most common of which, acquired immune deficiency syndrome (AIDS), occurred in 33 patients. Patients with normal immune function had self-limited diarrhea, but patients with immunologic abnormalities often developed severe, irreversible diarrhea; 22 patients have died. The diagnosis of cryptosporidiosis can now be made noninvasively, but increased diagnostic proficiency has led to little improvement in control or treatment of the disease. Although 23 compounds have been evaluated in experimentally infected animals and 20 drugs have been used in human clinical trials, no effective chemotherapeutic agent for cryptosporidiosis has been identified to date.

Why it matters

OpenAlex reports 314 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Cryptosporidium, an intestinal protozoan parasite, is a well-known cause of diarrhea in animals but has been recognized only recently as a cause of human disease. Since 1976, 58 cases of cryptosporidiosis in humans have been reported; 18 of the patients had normal immune function, and 40 had various immunologic abnormalities, the most common of which, acquired immune deficiency syndrome (AIDS), occurred in 33 patients. Patients with normal immune function had self-limited diarrhea, but patients with immunologic abnormalities often developed severe, irreversible diarrhea; 22 patients have died. The diagnosis of cryptosporidiosis can now be made noninvasively, but increased diagnostic proficiency has led to little improvement in control or treatment of the disease. Although 23 compounds have been evaluated in experimentally infected animals and 20 drugs have been used in human clinical trials, no effective chemotherapeutic agent for cryptosporidiosis has been identified to date.

Key concepts: Cryptosporidium, Medicine, Diarrhea, Immune system, Immunologic function, Disease, Immunology, Immunopathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Cryptosporidiosis: Clinical, Epidemiologic, and Parasitologic Review — Research Paper | ScholarLens